1. Home
  2. ABCL vs CERT Comparison

ABCL vs CERT Comparison

Compare ABCL & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • CERT
  • Stock Information
  • Founded
  • ABCL 2012
  • CERT 2008
  • Country
  • ABCL Canada
  • CERT United States
  • Employees
  • ABCL N/A
  • CERT N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • CERT Retail: Computer Software & Peripheral Equipment
  • Sector
  • ABCL Health Care
  • CERT Technology
  • Exchange
  • ABCL Nasdaq
  • CERT Nasdaq
  • Market Cap
  • ABCL 1.1B
  • CERT 1.3B
  • IPO Year
  • ABCL 2020
  • CERT 2020
  • Fundamental
  • Price
  • ABCL $3.61
  • CERT $9.24
  • Analyst Decision
  • ABCL Buy
  • CERT Buy
  • Analyst Count
  • ABCL 5
  • CERT 9
  • Target Price
  • ABCL $7.75
  • CERT $14.50
  • AVG Volume (30 Days)
  • ABCL 5.2M
  • CERT 2.8M
  • Earning Date
  • ABCL 11-06-2025
  • CERT 11-06-2025
  • Dividend Yield
  • ABCL N/A
  • CERT N/A
  • EPS Growth
  • ABCL N/A
  • CERT N/A
  • EPS
  • ABCL N/A
  • CERT 0.07
  • Revenue
  • ABCL $35,325,000.00
  • CERT $415,551,000.00
  • Revenue This Year
  • ABCL $16.99
  • CERT $11.70
  • Revenue Next Year
  • ABCL $62.91
  • CERT $8.03
  • P/E Ratio
  • ABCL N/A
  • CERT $135.12
  • Revenue Growth
  • ABCL 7.17
  • CERT 11.47
  • 52 Week Low
  • ABCL $1.89
  • CERT $8.03
  • 52 Week High
  • ABCL $6.52
  • CERT $15.69
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 33.35
  • CERT 42.93
  • Support Level
  • ABCL $3.33
  • CERT $8.03
  • Resistance Level
  • ABCL $3.83
  • CERT $8.91
  • Average True Range (ATR)
  • ABCL 0.27
  • CERT 0.59
  • MACD
  • ABCL -0.01
  • CERT 0.11
  • Stochastic Oscillator
  • ABCL 34.30
  • CERT 39.16

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Share on Social Networks: